Condition
Macular Pigment Optical Density
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed2
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05251792Unknown
Macular Pigment Optical Density in Primary Angle-closure Disease
NCT03433885UnknownPrimary
Wenzhou Dry Age-related Macular Degeneration (AMD) Progression Study
NCT03983525Not ApplicableCompletedPrimary
The Effect of Gojiberry Intake (Lycium Barbarium) on Macular Function
NCT00449917Phase 4CompletedPrimary
"Visiobiane Anti-age" Effects on Vision Parameters
Showing all 4 trials